Sharecafe

Investors Hang Up On Cellnet Raising

Unlike larger companies like Cochlear, Ramsay Healthcare, and National Australia Bank, a retail offer to small shareholders by wholesale mobile phone and accessories distributor Cellnet has bombed badly.

Is it all about size?

Unlike larger companies like Cochlear, Ramsay Healthcare, and National Australia Bank, a retail offer to small shareholders by wholesale mobile phone and accessories distributor Cellnet has bombed badly.

Cellnet raised $680,000 or just over a quarter of the $2.34 million it had been looking for from the issue.

About 150 valid applications were received for 22.64 million shares at 3c each, representing a take-up rate of about 16%.

In contrast, the NAB, Ramsay, and Cochlear all boosted the size of the retail offers to cope with higher demand.

The shortfall for Cellnet leaves Melbourne-based private equity firm and underwriter Thundering Herd with 55.4 million shares at a cost of $1.7 million and will make them the second-largest shareholder after chairman Michael Wendt.

An institutional offer conducted in early May was more successful, raising $2.73 million by issuing 91 million new shares at 3c per share to Wentronic, a company related to Mr. Wendt.

This takes his shareholding up to 81.18% of shares on issue.

As with the overwhelming majority of the recent run of capital raisings, the money will help Cellnet get through the COVID-19 pandemic.

Cellnet shares have dropped from 11c a year ago to a low of 4.1 cents two weeks ago. They last traded at 4c, down 20%. That was their low for the session.

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories